Ryan Birkland, DO
Interventional Pain Medicine · Rochester, MNNPI 1033590807
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (37.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 42.9% of the total. Reporting peaked in 2019 at $9,474 and has fallen 96.2% since, to $357 in 2025. Among interventional pain medicine clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $102.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Nevro Corp.$4K
- Abbott$2K
- Boston Scientific$1K
- AbbVie$325
- Stimwave Technologies Incorporated$282
- plus $724 from 10 others
What the payments were for
- Grants$5,62538%
- Travel & lodging$4,95133%
- Food & beverage$4,39829%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $6,421 |
| Nevro Corp. | 45 | $4,152 |
| Abbott | 26 | $1,692 |
| Boston Scientific | 18 | $1,378 |
| AbbVie | 24 | $325 |
| Stimwave Technologies Incorporated | 2 | $282 |
| Nalu Medical, Inc. | 1 | $234 |
| Si-bone, Inc. | 3 | $130 |
| Biotronik NRO, Inc. | 3 | $125 |
| SPR Therapeutics, Inc | 4 | $74 |
| Pacira Pharmaceuticals Incorporated | 1 | $48 |
| Vertos Medical, Inc. | 2 | $36 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| GRT US Holding, Inc. | 1 | $18 |
| Asahi Intecc USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,974 in reported general payments places this provider in the 90th percentile of 26 interventional pain medicine providers in Minnesota.
See all interventional pain medicine providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 137 | $2,443 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $630 |
| Pregabalin | 22 | $361 |
| Tizanidine Hcl | 22 | $233 |
| Methocarbamol | 18 | $114 |
| Baclofen | 11 | $107 |
| Duloxetine Hcl | 19 | $74 |
| Meloxicam | 16 | $30 |
| Diazepam | 22 | $19 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Rochester
- Gabriel Pagani-EstevezRochester$179K
- Gabriel SmithRochester$5K
- Nicholas CanzanelloRochester$4K
- Oludare OlatoyeRochester$3K
- Terry HuntRochester$2K
- William MauckRochester$2K
- Nima AdimiChaska$114K
- James ParmeleMaple Grove$13K
- Jason WolffMaple Grove$9K
- Gregory CrewdsonMaplewood$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.